Fiore Cannabis Ltd.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Erik Anderson
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- RPO Orchard Park Kelowna BC Canada V1Y 9N8
- IPO Date
- Sep 1, 2015
- Website
- fiorecannabis.com
- Similar Companies
- Business
- Fiore Cannabis Ltd. (CSE: FIOR; OTCQB: FIORF) cultivates, produces and distributes medical and recreational cannabis products as a multi-state operator in the United States with operations centered in Nevada and California; the company offers a diverse portfolio of branded cannabis flower, concentrates, extracts and wellness products including Fiore organic flower, Diamante Labs concentrates, PureCloud9, Gardens of WeEden, Blunt Box, Superior, Fiore Triple Certified, Diamante, Surfer and The Weekender brands, alongside retail sales through its Green Leaf Wellness dispensary in California's Coachella Valley focused on cannabis wellness items. Fiore maintains state-approved licenses in Nevada for medical and recreational cultivation, production and distribution, as well as a dispensary license in California, leveraging proprietary organic cultivation methods at its state-of-the-art Apex facility near Las Vegas to develop high-THC strains and related derivatives for recreational, medical and wellness markets. Founded in 2007 and headquartered in Kelowna, British Columbia, Canada, the company previously operated as Citation Growth Corp. until its name change in October 2020 and targets consumers and patients across North American legal jurisdictions with segments in cultivation, production, retail and hemp-derived products such as seed oil and skin care. Recent developments include the completion of a merger with Unified Global in May 2022, integrating the entity as an operating division to pursue up to 41 retail dispensaries and cultivation sites in Colorado, Oregon and Alberta as part of a Can-Am multi-state operator strategy; a non-binding term sheet in May 2022 for up to C$30 million equity financing from an institutional cannabis-focused fund; an expanded Nevada product portfolio rollout from the Apex facility starting in Q2 2021 encompassing additional extracts and brands; and license renewals in Las Vegas alongside executive and board resignations announced in late 2022, with the company delisted from the Canadian Securities Exchange amid a U.S.-centric growth focus.
7 Penny Stocks With 10x Potential This Year
Fiore Cannabis Ltd. (FIORF) CEO Erik Anderson on Q3 2021 Result - Earnings Call Transcript
Fiore Cannabis Reports First Quarterly Net Profit, Focuses On U.S. Possible Federal Legalization
Fiore Cannabis Provides Corporate Updates Including Developments at Apex Cannabis Facility in Las Vegas
Fiore Cannabis Announces Second Quarter 2021 Financial Results As Company Projects Strong Performance in Second Half of the Year
Fiore Cannabis Completes Sale of Celista, B.C. Asset to Put Major Focus on Core U.S. Markets
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
Fiore Cannabis Announces Debt Settlement Agreement To Further Strengthen Balance Sheet
Fiore Cannabis to Acquire California Cannabis Delivery Firm in $1.2 Million Transaction to Strengthen Market Focus
Fiore Cannabis Announces Expanded Product Portfolio for Nevada Market
Fiore Cannabis Closes Second and Final Tranche of Private Placement
Fiore Cannabis Closes First Tranche of Private Placement
Fiore Cannabis Announces Virtual AGM Details
Fiore Cannabis Announces Preliminary Revenue Performance for First Quarter 2021
Fiore Cannabis Announces Presentation at KCSA Cannabis Investor Conference
Fiore Cannabis Highlights Strong Cannabis Sales Surge in Nevada Market Still Recovering from Impacts of Pandemic
Fiore Cannabis Announces Private Placement to Fuel Expansion in U.S. Markets
Fiore Cannabis Directs Focus on Core U.S. Assets and Turnaround Position
Fiore Cannabis Announces Sale of Surplus Cannabis Licence to Fund Expansion of Apex Cultivation Facility
Fiore Cannabis Continues Strategic Program to Refocus on Core Assets